GOLDMAN SACHS GROUP INC - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOT and the CUSIP is G1125A108. A total of 77 filers reported holding BIOTECH ACQUISITION COMPANY in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q2 2022$2,300,0000.0%232,325
-0.4%
0.00%
Q1 2022$2,300,000
+0.2%
233,2250.0%0.00%
Q4 2021$2,295,000
+0.5%
233,225
-0.5%
0.00%
Q3 2021$2,283,000
+0.4%
234,419
-0.3%
0.00%
-100.0%
Q2 2021$2,273,000
+289.2%
235,019
+291.0%
0.00%
Q1 2021$584,00060,1040.00%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q4 2021
NameSharesValueWeighting ↓
Corbin Capital Partners, L.P. 928,124$9,040,0001.76%
DG Capital Management, LLC 450,000$4,383,0000.89%
Sage Rock Capital Management LP 573,800$5,589,0000.83%
Atalaya Capital Management LP 556,875$5,424,0000.83%
Telemetry Investments, L.L.C. 40,000$390,0000.53%
MMCAP International Inc. SPC 600,000$5,844,0000.41%
MANGROVE PARTNERS IM, LLC 300,000$2,922,0000.26%
DARK FOREST CAPITAL MANAGEMENT LP 74,328$724,0000.26%
Arena Capital Advisors, LLC- CA 300,000$2,922,0000.23%
PERISCOPE CAPITAL INC. 759,800$7,400,0000.22%
View complete list of BIOTECH ACQUISITION COMPANY shareholders